Clinical trials recruiting in Presidente Prudente, Brazil
5
Recruiting trials
7
Conditions
Phase breakdown
Phase 3 4Not applicable 1
Conditions recruiting in Presidente Prudente, Brazil
| Condition | Trials |
|---|---|
| Heart Failure | 3 |
| 24-Hour Movement Guidelines | 1 |
| Acute Heart Failure | 1 |
| Cardiovascular Risk Assessment | 1 |
| Chronic Kidney Disease | 1 |
| Rheumatoid Arthritis (RA) | 1 |
| Rheumatoid arthritis | 1 |
Recruiting trials in Presidente Prudente, Brazil
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Twenty-four Hour Movement Behaviors and Atherosclerotic Risk
Common questions
How many clinical trials are recruiting in Presidente Prudente, Brazil?
5 recruiting trials have at least one study site in Presidente Prudente, Brazil.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.